Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology*; D001952:Bridged-Ring Compounds / Q000494:pharmacology*; D011464:Epoprostenol / Q000494:pharmacology*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000494:pharmacology*; D011465:Prostaglandins, Synthetic / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D001095:Arachidonic Acids; D001643:Bridged Bicyclo Compounds; D001952:Bridged-Ring Compounds; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D016718:Arachidonic Acid; D000244:Adenosine Diphosphate; D011464:Epoprostenol